Haemonetics (HAE) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $86.22 +1.35%
Revenue Growth %: +8.4%
Financial Fact:
Net income: 0.39
Today's EPS Names:
TOWN, NRIM, GCBC, More
Revenue Growth %: +8.4%
Financial Fact:
Net income: 0.39
Today's EPS Names:
TOWN, NRIM, GCBC, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $0.39, $0.01 better than the analyst estimate of $0.38. Revenue for the quarter came in at $228.1 million versus the consensus estimate of $219.42 million.
GUIDANCE:
Haemonetics sees FY2018 EPS of $1.55-$1.65, versus the consensus of $1.59.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- SLM (SLM) Tops Q1 EPS by 20c; offers guidance
- Amerant Bancorp Inc. (AMTB) Misses Q1 EPS by 5c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
